Keyword: Pharmaceuticals

News

Number of New Drugs Picks Up in Europe and U.S.

19.12.2012 - The number of new medicines approved or pending approval is on the rise on both sides of the Atlantic, painting an encouraging picture for the global drugs industry as it emerges...

News

Amgen Pleads Guilty to Misbranding Charges, Will Pay $762 Million

18.12.2012 - Amgen pleaded guilty in a federal court in New York on Tuesday to misbranding its Aranesp anemia drug and agreed to pay $762 million in a civil settlement and criminal fines. The...

News

Lundbeck's Alcohol Dependency Drug Gets EU Green Light

18.12.2012 - A novel drug to fight alcohol dependency was given a green light by European regulators on Friday, providing a boost to Danish drugmaker Lundbeck at a time when its top product...

News

EU Agency Rejects Sanofi, Isis Cholesterol Drug

18.12.2012 - European regulators recommended against approval of Sanofi and Isis Pharmaceutical's Kynamro drug for treatment of a rare genetic disorder that causes unusually high cholesterol...

News

More Pressure to Justify Cost of Cancer Drugs Versus Benefits

14.12.2012 - Medical providers have begun to think more about cost, as well as safety and effectiveness, when they decide on cancer treatments. In the past, pharmaceutical companies could...

News

Novo Bets on High-Price Niche for Obesity Drug

11.12.2012 - Denmark's Novo Nordisk is sizing up a high-price niche market for its drug liraglutide as a weight-loss treatment, with the United States the prime opportunity. The premium-price...

News

Amgen Buys Icelandic Gene Pioneer Decode for $415 Million

10.12.2012 - U.S. biotechnology group Amgen has agreed to buy unlisted Decode Genetics, a pioneer in gene research, for $415 million to boost its drive to develop better targeted drugs. Founded...

News

Bayer Diabetes Unit Sale Unlikely

07.12.2012 - Bayer is unlikely to sell its blood glucose meters business for the time being, after failing to generate sufficient interest from buyers, two people familiar with the situation...